Kluz Ventures

Kluz Ventures is a venture capital firm established in 2010 and located in Rockville, Maryland. The firm focuses on investing in early and growth-stage companies that are developing disruptive technologies. Its investment portfolio spans various sectors, including software, media, consumer products, robotics, biotechnology, digital health, medical technology, wealth technology, satellites, financial technology, augmented reality, virtual reality, health technology, software-as-a-service, cybersecurity, and blockchain. Kluz Ventures primarily targets opportunities in the United States and Europe, aiming to support innovative enterprises that have the potential to drive significant advancements in their respective fields.

Artur Kluz

Managing Partner

7 past transactions

Secro

Seed Round in 2023
Secro is an early-stage startup focused on developing a supply chain platform that aims to enhance global trade by addressing issues of fraud, inefficiencies, and exploitation. Founded in 2021 and headquartered in Wilmington, Delaware, Secro offers a cloud-based solution that allows organizations to securely collaborate on various functions essential for managing complex cross-border transactions. The platform features end-to-end paperless workflows, including e-bills of lading and tools for contract negotiation and execution. Additionally, it employs advanced technology to vet customers, safeguard data, and detect suspicious behavior, ensuring confidentiality throughout the process. By facilitating more equitable trade practices, Secro seeks to create opportunities for underprivileged communities affected by globalization.

Strolll

Pre Seed Round in 2021
Strolll is a digital health startup focused on creating solutions to enhance mobility for individuals with neurological disorders. The company develops extended reality digital therapeutics that empower movement therapy through innovative approaches. Its offerings include augmented reality services designed for cueing therapy and gamified exercise, aimed at improving gait and balance while reducing the risk of falls for patients with conditions such as Parkinson's disease. By providing these therapeutic tools, Strolll enables individuals to better manage their neurological disorders and improve their overall quality of life.

PhishAR

Seed Round in 2020
PhishAR is a cybersecurity company focused on combating phishing-based financial fraud, ransomware, and social engineering attacks. It leverages artificial intelligence and augmented reality technologies to enhance online security for users. By analyzing elements such as email formatting, URLs, and requested information, PhishAR's platform identifies fraudulent emails, websites, and online transactions. This proactive approach empowers users to recognize potential threats and protect themselves from cyber attacks, ensuring a safer online experience.

Vigilant Aerospace Systems

Debt Financing in 2019
Vigilant Aerospace Systems, Inc. is a technology company based in Oklahoma City, Oklahoma, that specializes in the licensing and commercialization of NASA flight safety technologies. Founded in 2015, the company develops and markets advanced situational awareness and collision avoidance products for both manned and unmanned aircraft. Its flagship avionics software platform, FlightHorizon, offers synthetic cockpit views and detect-and-avoid capabilities, utilizing a range of sensors including ADS-B in signals. Vigilant Aerospace is recognized as a leader in the development of multi-sensor detect-and-avoid systems and airspace management software for uncrewed aircraft systems (UAS), enabling safe and scalable autonomous flight beyond visual line of sight. The company's clientele includes prominent organizations such as NASA, the FAA, and the U.S. Department of Defense, as well as various drone development programs.

TruWeather Solutions

Seed Round in 2019
TruWeather Solutions, Inc. is a weather forecasting service provider based in Reston, Virginia, established in 2019. The company specializes in developing a weather risk management framework, particularly for aviation and logistics industries, by integrating weather data into operational planning. Its primary offering, the TruFlite V360° platform, is a Software as a Service (SaaS) solution designed to enhance the precision and accuracy of weather intelligence. This platform supports drone teams, dispatchers, and schedulers by providing live forecasting, alerting, and consulting services. By utilizing advanced micro weather analytics and real-time technology, TruWeather Solutions enables clients to optimize flight time and improve operational efficiency while effectively managing weather-related risks.

Syncurity

Seed Round in 2018
Syncurity Corporation specializes in developing network security monitoring and incident response solutions for businesses. Based in Arlington, Virginia, the company offers IR-Flow, a comprehensive security alert and incident response management system designed to enhance efficiency and effectiveness for security teams. This solution enables organizations to remediate incidents before they escalate into breaches while providing real-time visibility and insights. IR-Flow serves as a scalable cybersecurity incident response workspace, facilitating streamlined operations, compliance, and collaboration among security professionals. Syncurity focuses on optimizing the integration of people, processes, and technology to improve cybersecurity outcomes. In 2020, Syncurity became a subsidiary of Swimlane, Inc.

Cypre

Convertible Note in 2018
Cypre, Inc. is a biotechnology company based in San Francisco, California, founded in 2016. It focuses on developing innovative 3D in vitro models of the tumor microenvironment (TME) to enhance cancer drug discovery. Cypre employs proprietary high-content imaging algorithms and advanced hydrogel technology to provide insights into therapeutic mechanisms for various treatment modalities, including small molecules, antibodies, and cell and gene therapy. The company's platform utilizes patented three-dimensional bioprinting technology combined with methods that assess immunotherapy efficacy, enabling medical institutions to effectively identify therapeutics that can overcome resistance to cancer treatments. Cypre's solutions are particularly relevant in the fields of oncology, immuno-oncology, disease modeling, and stem cell research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.